Literature DB >> 21745189

Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells.

N M Rogers1, M D Stephenson, A R Kitching, J D Horowitz, P T H Coates.   

Abstract

BACKGROUND AND
PURPOSE: Renal ischaemia-reperfusion (IR) injury is an inevitable consequence of renal transplantation, causing significant graft injury, increasing the risk of rejection and contributing to poor long-term graft outcome. Renal injury is mediated by cytokine and chemokine synthesis, inflammation and oxidative stress resulting from activation of the NF-κB pathway. EXPERIMENTAL APPROACH: We utilized liposomal incorporation of a potent inhibitor of the NF-κB pathway, curcumin, to target delivery to renal tubular epithelial and antigen-presenting cells. Liposomes containing curcumin were administered before bilateral renal ischaemia in C57/B6 mice, with subsequent reperfusion. Renal function was assessed from plasma levels of urea and creatinine, 4 and 24 h after reperfusion. Renal tissue was examined for NF-κB activity and oxidative stress (histology, immunostaining) and for apoptosis (TUNEL). Cytokines and chemokines were measured by RT-PCR and Western blotting. KEY
RESULTS: Liposomal curcumin significantly improved serum creatinine, reduced histological injury and cellular apoptosis and lowered Toll-like receptor-4, heat shock protein-70 and TNF-α mRNA expression. Liposomal curcumin also reduced neutrophil infiltration and diminished inflammatory chemokine expression. Curcumin liposomes reduced intracellular superoxide generation and increased superoxide dismutase levels, decreased inducible NOS mRNA expression and 3-nitrotyrosine staining consistent with limitations in nitrosative stress and inhibited renal tubular mRNA and protein expression of thioredoxin-interacting protein. These actions of curcumin were mediated by inhibition of NF-κB, MAPK and phospho-S6 ribosomal protein. CONCLUSIONS AND IMPLICATIONS: Liposomal delivery of curcumin promoted effective, targeted delivery of this non-toxic compound that provided cytoprotection via anti-inflammatory and multiple antioxidant mechanisms following renal IR injury.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21745189      PMCID: PMC3415648          DOI: 10.1111/j.1476-5381.2011.01590.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  58 in total

Review 1.  NF-kappaB in transplantation: friend or foe?

Authors:  G Tsoulfas; D A Geller
Journal:  Transpl Infect Dis       Date:  2001-12       Impact factor: 2.228

2.  High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

Authors:  Weier Qi; Xinming Chen; Richard E Gilbert; Yuan Zhang; Mark Waltham; Maria Schache; Darren J Kelly; Carol A Pollock
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.

Authors:  Pay-Chin Leow; Quan Tian; Zhan-Yuin Ong; Zheng Yang; Pui-Lai Rachel Ee
Journal:  Invest New Drugs       Date:  2010-12       Impact factor: 3.850

Review 4.  Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease.

Authors:  R A Preston; M Epstein
Journal:  J Hypertens       Date:  1997-12       Impact factor: 4.844

5.  Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.

Authors:  M C Heng; M K Song; J Harker; M K Heng
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

Review 6.  Organ reperfusion and preservation.

Authors:  Russell W Jamieson; Peter J Friend
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  New cellular and molecular immune pathways in ischemia/reperfusion injury.

Authors:  P Boros; J S Bromberg
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

8.  Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase.

Authors:  S Reddy; B B Aggarwal
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

9.  Inhibition of human immunodeficiency virus type-1 integrase by curcumin.

Authors:  A Mazumder; K Raghavan; J Weinstein; K W Kohn; Y Pommier
Journal:  Biochem Pharmacol       Date:  1995-04-18       Impact factor: 5.858

10.  Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications.

Authors:  M Balasubramanyam; A Adaikala Koteswari; R Sampath Kumar; S Finny Monickaraj; J Uma Maheswari; V Mohan
Journal:  J Biosci       Date:  2003-12       Impact factor: 2.795

View more
  16 in total

1.  ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease.

Authors:  Kristin M Poole; Christopher E Nelson; Rucha V Joshi; John R Martin; Mukesh K Gupta; Skylar C Haws; Taylor E Kavanaugh; Melissa C Skala; Craig L Duvall
Journal:  Biomaterials       Date:  2014-12-09       Impact factor: 12.479

2.  Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus - insights into its mechanisms of action.

Authors:  B Stefanska
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury.

Authors:  Natasha M Rogers; Angus W Thomson; Jeffrey S Isenberg
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

4.  Protective effect of epigallocatechin gallate, a major constituent of green tea, against renal ischemia-reperfusion injury in rats.

Authors:  Jun Lv; Min Feng; LiLi Zhang; Xia Wan; Yu Chun Zeng; Pei Fen Liang; An Ping Xu
Journal:  Int Urol Nephrol       Date:  2015-06-28       Impact factor: 2.370

5.  PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.

Authors:  Karoly Kalmar-Nagy; Peter Degrell; Aliz Szabo; Katalin Sumegi; Istvan Wittmann; Ferenc Gallyas; Balazs Sumegi
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

Review 6.  Current Antioxidant Treatments in Organ Transplantation.

Authors:  Shaojun Shi; Feng Xue
Journal:  Oxid Med Cell Longev       Date:  2016-06-15       Impact factor: 6.543

7.  Therapeutic effects of curcumin on the functional disturbances and oxidative stress induced by renal ischemia/reperfusion in rats.

Authors:  Houshang Najafi; Saeed Changizi Ashtiyani; Sayed Abolhasan Sayedzadeh; Zeynab Mohamadi Yarijani; Sajad Fakhri
Journal:  Avicenna J Phytomed       Date:  2015 Nov-Dec

8.  Molecular Mechanisms of Curcumin Renoprotection in Experimental Acute Renal Injury.

Authors:  Youling Fan; Hongtao Chen; Huihua Peng; Fang Huang; Jiying Zhong; Jun Zhou
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

Review 9.  Nanocurcumin: A Promising Candidate for Therapeutic Applications.

Authors:  Adhimoolam Karthikeyan; Natesan Senthil; Taesun Min
Journal:  Front Pharmacol       Date:  2020-05-01       Impact factor: 5.810

Review 10.  Nanotechnology-applied curcumin for different diseases therapy.

Authors:  Negar Ghalandarlaki; Ali Mohammad Alizadeh; Soheil Ashkani-Esfahani
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.